This indicates that the abnormal expression of CXCL8 in CTEPH may inhibit or activate the functions of other genes, thus playing a regulatory mechanism in the development of CTEPH. This evidence concerns the gene CXCL8 and chronic thromboembolic pulmonary hypertension.